z-logo
open-access-imgOpen Access
What is The Case of More Accessible Treatment Options in COVID 19: Comparison of Hydroxychloroquine and Favipiravir Based on Laboratory Values?
Author(s) -
Buket Mermit Çilingir,
Aysel Sünnetçioğlu,
Hanifi Yıldız,
Berrak Mermit Erçek,
Nuruban Delal Baykal
Publication year - 2021
Publication title -
easterns journal of medicine/eastern journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.123
H-Index - 10
eISSN - 1309-3886
pISSN - 1301-0883
DOI - 10.5505/ejm.2021.46548
Subject(s) - favipiravir , medicine , hydroxychloroquine , pneumonia , covid-19 , gastroenterology , disease , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here